IP Library Granted Patent US 11,008,550
Granted Patent B2
US 11,008,550 · App. 16/250,366 · Granted May 18, 2021

Use of RNA for reprogramming somatic cells

Inventors: Ugur Sahin (Mainz, DE); Marco Poleganov (Frankfurt, DE); Tim Beissert (Griesheim, DE)
C12N5/0696C12N2501/602C12N2501/603C12N2501/604C12N2501/606C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,008,550
App. No.
16/250,366
Granted
May 18, 2021
Kind
B2
Abstract

The present invention provides methods for de-differentiating somatic cells into stem-like cells without generating embryos or fetuses. More specifically, the present invention provides methods for effecting the de-differentiation of somatic cells to cells having stem cell characteristics, in particular pluripotency, by introducing RNA encoding factors inducing the de-differentiation of somatic cells into the somatic cells and culturing the somatic cells allowing the cells to de-differentiate.

Claims (4)

1. A RNA-transfected somatic cell population which comprises somatic cells subjected to electroporation, containing in vitro transcribed mRNA encoding OCT4, SOX2, KLF4 and c-MYC, wherein the 5′-Cap of said mRNA consists of the D1 isomer of m 2 7,2′-0 GppspG and wherein the transfected cell population expresses alkaline phosphatase and expresses endogenous OCT4, for at least 7 days.

2. The RNA-transfected somatic cell population in accordance with claim 1 wherein the somatic cells are human cells.

3. The RNA-transfected somatic cell population in accordance with claim 2 wherein the human cells are adult human dermal fibroblasts.

4. The RNA transfected somatic cell population in accordance with claim 1 wherein the somatic cells are fibroblasts.

Assignments (1)
CHANGE OF NAME Recorded Jun 16, 2021
From: BIONTECH AG
To: BIONTECH SE
Reel/Frame 056612/0563 →
Priority Claims (1)
EP 07024312 · Dec 14, 2007 · regional
Continuity (4)
Continuation 15485601 · Apr 12, 2017
Continuation 14933840 · Nov 5, 2015
Continuation 12735060
Related Publication 20190194623A1 · Jun 27, 2019